UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.
In a study examining the link between non-alcoholic fatty liver disease (NAFLD) and brain dysfunction, scientists at the Roger Williams Institute of Hepatology, affiliated to King’s College London and the University of Lausanne, found an accumulation of fat in the liver causes a decrease in oxygen to the brain and inflammation to brain tissue – both of which have been proven to lead to the onset of severe brain diseases.
Algal blooms or cylindrospermopsin, exacerbated by climate change, shown to have a connection with several adverse health effects.
A brief roundup of news and story ideas from the experts at UCLA Health.
In light of the recent pandemic, people across the globe are increasingly becoming aware of the importance of consistent high-quality nutrition and daily exercise.
For patients with acute liver failure (ALF) and acute-on-chronic liver failure (ACLF), the toxins that build up in their blood can cause confusion, tremors, vomiting, abdominal pain and stomach swelling. Having a liver unable to clean the body's blood is a life-threatening condition, and patients are told to seek immediate medical assistance.
The December issue of The American Journal of Gastroenterology features multi-society collaborations on diversity, equity, and inclusion, as well as the role of the GI profession in climate change issues. Interestingly, this issue includes a thought-provoking line of inquiry from Brennan Spiegel, MD, MSHS, FACG, who hypothesizes that gravity may play a role in IBS.
A Rutgers analysis showed that early signs of liver damage from high-dose green tea extract were somewhat predicted by one variation in a genotype and strongly predicted by another variation.
Patients with inflammatory bowel diseases (IBD) who required treatment and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.
Debashish Bose, M.D., PhD, FACS, Medical Director of Surgical Oncology at Mercy and The Center for Hepatobiliary Disease at Mercy, is the guest for the hospital’s ongoing talk show series, “Medoscopy,” airing on Facebook Watch, Tues.-Wed., Nov. 29th and 30th at 5:30 p.m. EST
Leprosy is one of the world’s oldest and most persistent diseases but the bacteria that cause it may also have the surprising ability to grow and regenerate a vital organ.
A Rutgers study of obese adults, all with nonalcoholic fatty liver disease (NAFLD) and morbid obesity (body mass index > 40), has shown that those who underwent bariatric surgery suffered far fewer extreme cardiovascular events subsequently.
Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.
A pioneering protocol developed at Children’s Hospital Los Angeles is reducing overall opioid use, speeding rehabilitation and shortening intensive care unit (ICU) stays for pediatric liver transplant patients—including infants as young as 5 months old.
A ToxSpotlight article in the November 2022 issue of ToxSci assesses the mechanism for cellular accumulation of diglycolic acid while another explores the effect of long-term St. John’s wort administration on acetaminophen-induced acute hepatotoxicity and the involved mechanisms.
New study identifies that first-degree relatives of patients with nonalcoholic fatty liver disease with advanced fibrosis (scarring of the liver) are at a 15% risk of developing the condition.
New research led by researchers at the University of Miami Miller School of Medicine and published in the Journal of Hepatology, suggests that getting a third dose of the COVID-19 mRNA vaccine could overcome the decreased vaccine respons in cirrhosis patients and offer strong protection against the virus, severe illness, and death from COVID-19.
Adding radiation therapy to systemic therapy for patients with advanced liver cancer can extend overall survival and delay tumor progression without compromising patients’ quality of life, a randomized phase III clinical trial shows.
The latest articles that have been added to the Environmental Health channel.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
